HEMA312 FINALS

123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778
Across
  1. 3. also known as brittle bone disease.
  2. 6. inactives protein that promotes blood clots and acts with protein c.
  3. 12. increased levels of uremic toxins such as guanidosuccinic acid and phenols.
  4. 15. the removal, return, or exchange of blood plasma or components.
  5. 16. illness that develops at some point during its life.
  6. 18. phenomenon that occurs to platelets iin Kasabach-Merritt Syndrome.
  7. 20. plaque in the artery causing blockage that may lead to Myocardial infarction.
  8. 22. enzyme-linked immunoabsorbent assay.
  9. 23. Factor VII.
  10. 27. characterized by an increase in the circulating platelet counts greater than 450,000/uL.
  11. 28. a specific von Willebrand factor-cleaving metalloprotease found in plasma.
  12. 30. breaking down of elastic fibers.
  13. 32. serine protease inhibitor (serpin) that neutralizes thrombin, Factor Ixa, Xa, Xia & XIIa.
  14. 36. type of VWD that is an autosomal recessive or severe type.
  15. 38. other name of purpura simplex.
  16. 41. most frequently used coumarin which is water soluble and administered orally.
  17. 45. the treatment of choice for ITP.
  18. 46. a protein responsible for stabilizing the platelet plug.
  19. 47. it is a syndrome related to preeclampsia/eclampsia, defined by elevated liver enzymes, and low platelet count.
  20. 49. a sudden or quick emergence of a condition.
  21. 52. commonly used to decrease the period of thrombocytopenia in ITP.
  22. 54. nose bleeding.
  23. 55. removal of a body part such as finger, toe, hand, foot, or leg.
  24. 57. this is the one that is absent in a platelet disorder, with a mutation in the RBM8A in chromosome 1.
  25. 59. enlargement of the spleen.
  26. 61. most common infectious agent causing neonatal thrombocytopenia.
  27. 62. jew people with hemophilia C.
  28. 63. a platelet disorder with mutation in the (blank).
  29. 65. spontaneous remissions with or without therapy like Idiophatic Thrombocytopenic Purpura.
  30. 67. a surgical procedure to remove the spleen.
  31. 68. a prolonged period of menstruation in adult ITP.
  32. 70. an anomaly characterized by macrothrombocytopenia with dohle-like bodies.
  33. 72. excessive amount of protein, associated with multiple myeloma and waldenstrom macroglobulinemia.
  34. 73. a bleeding disorder characterized by problem with GPIIB-IIIA
  35. 74. a condition in which the tissue lining of the heart becomes inflamed caused by bacteria.
  36. 76. a zymogen that is cleaved to form plasmin.
  37. 77. soluble protein that is broken down to fibrin.
  38. 78. small red spot that appears on the skin.
Down
  1. 1. inherited from parents to their offspring.
  2. 2. overreactive function of spleen, increasing the destruction of platelets.
  3. 4. deficiency resulting from a lack of vitamin C.
  4. 5. an autosomal-dominant genetic syndrome due to mutation of the gene for fibrillin resulting in abnormalities of connective tissues and risk for bleeding and bruising.
  5. 7. a syndrome known as X-linked hereditary with mutation in GTA 1 gene.
  6. 8. this is a factor VIII:C deficiency, also known as royal disease.
  7. 9. total lack of fibrinogen.
  8. 10. treatment for afibrinogenemia.
  9. 11. a severe form of bleeding that requires immediate intervention and transfusion.
  10. 13. coughing up blood.
  11. 14. clinical manifestation of red blood cell extravasation into mucosa or skin
  12. 17. it attacks platelets of the fetal, seen in neonatal alloimmune thrombocytopenia (NAIT).
  13. 19. defined by the occurrence of acute neurologic abnormalities in a preeclamptic woman during peripartum period.
  14. 20. immediate systemic reactions that mimic anaphylaxis but are not caused by IgE-mediated immune responses.
  15. 21. intravenous anticoagulant most commonly used in clinical medicine.
  16. 24. cofactor of thrombin that inhibits procoagulant function.
  17. 25. a syndrome characterized with macrothrombocytopenia without dohle-like bodies.
  18. 26. long time or persistent clinical condition.
  19. 28. spontaneous bleeding caused by deposition of amyloid protein around small vessels.
  20. 29. purple-bluish bruise caused by broken blood vessels.
  21. 31. refers to an increased tendency to develop thrombi or emboli.
  22. 33. sudden appearance of symptoms, change, or worsen rapidly.
  23. 34. dysfunctional fibrinogen.
  24. 35. most frequent causes of drug-induced thrombocytopenia where it acts as a hapten.
  25. 37. a therapy for HIV patients.
  26. 39. deficiency in fibrinogen.
  27. 40. serious condition in which the body responds improperly to an infection.
  28. 42. defined by hypertension and proteinuria; usually becomes evident during the second trimester and is a major contributor to maternal and fetal morbidity and mortality.
  29. 43. a machine filters the wastes, salts, and fluids from the blood when kidneys no longer function.
  30. 44. significant decrease in all blood cells.
  31. 48. bleeding in joints.
  32. 50. production of cryoprecipitable serum proteins or protein complexes.
  33. 51. regulatory protein.
  34. 53. the name of purpura commonly seen in children that is typically reversible.
  35. 56. surface activator used in APTT
  36. 58. fragmented RBC that is also known as helmet cells.
  37. 60. a serine protease responsible for fibrin degradation during fibrinolysis.
  38. 64. swelling of legs or arms caused by build-up of fluid in the tissue.
  39. 66. anything that moves through blood vessels until it gets stuck in a vessel that’s too small to pass through.
  40. 69. reduction in the number or quantity.
  41. 71. type of tissue death caused by a lack of blood supply.
  42. 75. a pharmacological agent, 1-desamino-8-D-arginine-vasopressin.